Eliem Therapeutics Pre-Paid Expenses 2021-2024 | CLYM
Eliem Therapeutics pre-paid expenses from 2021 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
Eliem Therapeutics Annual Pre-Paid Expenses (Millions of US $) |
2023 |
$3 |
2022 |
$11 |
2021 |
$12 |
2020 |
$2 |
Eliem Therapeutics Quarterly Pre-Paid Expenses (Millions of US $) |
2024-06-30 |
$3 |
2024-03-31 |
$4 |
2023-12-31 |
$3 |
2023-09-30 |
$5 |
2023-06-30 |
$12 |
2023-03-31 |
$11 |
2022-12-31 |
$11 |
2022-09-30 |
$11 |
2022-06-30 |
$10 |
2022-03-31 |
$9 |
2021-12-31 |
$12 |
2021-09-30 |
$13 |
2021-06-30 |
$5 |
2021-03-31 |
|
2020-12-31 |
|
2020-09-30 |
|
2020-06-30 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-DRUGS |
$0.342B |
$0.000B |
Eliem Therapeutics Inc. is a clinical-stage biotechnology company. It focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Eliem Therapeutics Inc. is based in SEATTLE, United Kingdom.
|